Regeneron Pharmaceuticals (NasdaqGS:REGN) Q3 2025 Earnings Call October 28, 2025 08:30 AM ET Company ParticipantsGeorge Yancopoulos - President and CSOChris Fenimore - CFOMarion McCourt - EVP of CommercialLeonard Schleifer - President and CEORyan Crowe - SVP of Investor RelationsConference Call ParticipantsSimon Goodwin - AnalystJeffrey Meacham - AnalystTerrence Flynn - AnalystBrian Abrahams - AnalystAkash Tewari - AnalystSalveen Richter - AnalystTyler Van Buren - AnalystAlexandria Hammond - AnalystCory Kas ...

Regeneron Corporate Presentation O C T O B E R 2 0 2 5 This non-promotional presentation contains investigational data as well as forward-looking statements; actual results may vary materially. Note regarding forward-looking statements and non-GAAP financial measures This presentation includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may ...